Logout Login Cart iconShop
Contact Sales

Search

Filters

Content Type

Products

Clear Filters

Search Results for "fc coins satin al Visit Buyfc26coins.com for latest FC 26 coins news..XeZ3"

Looking for quality documents?
external link icon
Repligen Reports Third Quarter Fiscal Year 2009 Financial Results
external link icon
Repligen Reports Second Quarter Fiscal Year 2009 Financial Results
external link icon
Repligen Reports First Quarter Fiscal Year 2009 Financial Results
external link icon
Repligen Reports Third Quarter Fiscal Year 2008 Financial Results
external link icon
Repligen Announces Conference Call to Discuss Phase 3 Clinical Trial Results of RG1068 in Pancreatic Imaging
external link icon
Repligen to Present at the Lazard Capital Markets 7th Annual Healthcare Conference Wednesday, November 17th, 2:45 p.m. EST
external link icon
Repligen Announces Conference Call of Fourth Quarter and Fiscal Year 2010 Financial Results Wednesday, June 9th 10:00 a.m. EDT
external link icon
Repligen to Present at the 38th Annual J.P. Morgan Healthcare Conference
WALTHAM, Mass., Jan. 07, 2020 (GLOBE NEWSWIRE) - Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced that the Company will present at the 38 th annual J.P. Morgan Healthcare Conference, to be held at the Westin St. Francis in San Francisco. Tony J. Hunt, Repligen’s president and chief executive officer, is scheduled to present a company overview on Wednesday, January 15, 2020 at 11:30 a.m. PT.

A live audio webcast of the presentation will be accessible through the Investor Events section of the Company’s website at www.repligen.com . A recorded replay will be available approximately one hour after the conclusion of the live event, and will be accessible for up to 90 days following the event.

About Repligen Corporation
Repligen Corporation is a global life sciences company that develops and commercializes highly innovative bioprocessing technologies and systems that increase
external link icon
Repligen to Present at 37th Annual J.P. Morgan Healthcare Conference
WALTHAM, Mass., Jan. 03, 2019 (GLOBE NEWSWIRE) - Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced that it will present at the 37 th Annual J.P. Morgan Healthcare conference being held January 7-10 at the Westin St. Francis in San Francisco.  Tony J. Hunt, President and Chief Executive Officer, will make a formal presentation on Tuesday, January 8, at 5:30 p.m. PST.

A live webcast of the presentation will be accessible through the Investor Events section of the Company’s website, and will be available for replay for a limited period of time following the conference event.

About Repligen Corporation
Repligen Corporation (NASDAQ:RGEN) is a bioprocessing-focused company that develops and commercializes highly innovative products that deliver cost and process efficiencies to biological drug manufacturers worldwide. Our portfolio includes protein products (Protein A affinity
external link icon
Repligen To Present at 36th Annual J.P. Morgan Healthcare Conference
WALTHAM, Mass., Dec. 29, 2017 (GLOBE NEWSWIRE) - Repligen Corporation (NASDAQ:RGEN), a leading bioprocessing-focused company delivering technology innovation to improve biologic drug manufacturing flexibility and efficiency, today announced that the Company will be presenting at the 36 th Annual J.P. Morgan Healthcare Conference, being held January 8-11, 2018 in San Francisco. Tony J. Hunt, President and CEO of Repligen, will present a company overview on Tuesday, January 9 at 4:00 p.m. PT. 
A live webcast of the event will be accessible through the Investor Relations section of Repligen’s website. This webcast will be archived for a period of time following the live event.
About Repligen Corporation
Repligen Corporation (NASDAQ:RGEN) is a global bioprocessing company that develops and commercializes highly innovative products that deliver cost and process efficiencies to biological drug manufacturers worldwide. Our portfolio includes protein products (Protein
Close modal

A new look. A better way to explore Repligen.

We’ve redesigned Repligen.com to help you find the right solutions faster, with greater clarity and less effort.

Find what you need faster
Get to the right information with quicker site speed

Explore the site with ease
Navigate easily with an intuitive, simple site structure

Access product details instantly
Find products and resources faster, in fewer clicks

Get support when you need it
Connect with our team when you need support